These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 31410208)
41. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells. Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267 [TBL] [Abstract][Full Text] [Related]
42. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma. Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634 [TBL] [Abstract][Full Text] [Related]
43. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871 [TBL] [Abstract][Full Text] [Related]
44. High-Mobility Group Box 1 (HMGB1) Induces Migration of Endothelial Progenitor Cell via Receptor for Advanced Glycation End-Products (RAGE)-Dependent PI3K/Akt/eNOS Signaling Pathway. Zhang Y; You B; Liu X; Chen J; Peng Y; Yuan Z Med Sci Monit; 2019 Aug; 25():6462-6473. PubMed ID: 31461437 [TBL] [Abstract][Full Text] [Related]
45. MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition. Wang L; Song G; Tan W; Qi M; Zhang L; Chan J; Yu J; Han J; Han B Oncotarget; 2015 Nov; 6(34):35978-90. PubMed ID: 26451614 [TBL] [Abstract][Full Text] [Related]
46. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers. Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831 [TBL] [Abstract][Full Text] [Related]
47. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling. Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214 [TBL] [Abstract][Full Text] [Related]
48. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition. Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363 [TBL] [Abstract][Full Text] [Related]
49. AKT/GSK-3β regulates stability and transcription of snail which is crucial for bFGF-induced epithelial-mesenchymal transition of prostate cancer cells. Liu ZC; Wang HS; Zhang G; Liu H; Chen XH; Zhang F; Chen DY; Cai SH; Du J Biochim Biophys Acta; 2014 Oct; 1840(10):3096-105. PubMed ID: 25088797 [TBL] [Abstract][Full Text] [Related]
50. Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling. Wang Y; Liang Y; Yang G; Lan Y; Han J; Wang J; Yin D; Song R; Zheng T; Zhang S; Pan S; Liu X; Zhu M; Liu Y; Cui Y; Meng F; Zhang B; Liang S; Guo H; Liu Y; Hassan MK; Liu L J Exp Clin Cancer Res; 2018 Dec; 37(1):300. PubMed ID: 30514341 [TBL] [Abstract][Full Text] [Related]
51. High-Mobility Group Box 1 (HMGB1) Promotes Angiogenesis and Tumor Migration by Regulating Hypoxia-Inducible Factor 1 (HIF-1α) Expression via the Phosphatidylinositol 3-Kinase (PI3K)/AKT Signaling Pathway in Breast Cancer Cells. He H; Wang X; Chen J; Sun L; Sun H; Xie K Med Sci Monit; 2019 Apr; 25():2352-2360. PubMed ID: 30930461 [TBL] [Abstract][Full Text] [Related]
52. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway. Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138 [TBL] [Abstract][Full Text] [Related]
53. Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling. Ren Y; Cao L; Wang L; Zheng S; Zhang Q; Guo X; Li X; Chen M; Wu X; Furlong F; Meng Z; Xu K Cell Death Dis; 2021 Sep; 12(10):858. PubMed ID: 34552063 [TBL] [Abstract][Full Text] [Related]
54. Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis. Wu JB; Shao C; Li X; Li Q; Hu P; Shi C; Li Y; Chen YT; Yin F; Liao CP; Stiles BL; Zhau HE; Shih JC; Chung LW J Clin Invest; 2014 Jul; 124(7):2891-908. PubMed ID: 24865426 [TBL] [Abstract][Full Text] [Related]
55. PEBP4 silencing inhibits hypoxia-induced epithelial-to-mesenchymal transition in prostate cancer cells. Li W; Dong Y; Zhang B; Kang Y; Yang X; Wang H Biomed Pharmacother; 2016 Jul; 81():1-6. PubMed ID: 27261570 [TBL] [Abstract][Full Text] [Related]
56. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer. Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945 [TBL] [Abstract][Full Text] [Related]
57. HSPC159 promotes proliferation and metastasis by inducing epithelial-mesenchymal transition and activating the PI3K/Akt pathway in breast cancer. Zheng J; Zhang M; Zhang L; Ding X; Li W; Lu S Cancer Sci; 2018 Jul; 109(7):2153-2163. PubMed ID: 29737572 [TBL] [Abstract][Full Text] [Related]
58. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway. Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788 [TBL] [Abstract][Full Text] [Related]
59. Exportin XPO7 acts as an oncogenic factor in prostate cancer via upregulation of TCF3. Lin Y; Zhan M; Xu B J Cancer Res Clin Oncol; 2023 Aug; 149(10):7663-7677. PubMed ID: 37000263 [TBL] [Abstract][Full Text] [Related]
60. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells. Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]